The SPDR ETF holds major pharmaceutical companies including Johnson & Johnson, Amgen, Eli Lilly, AbbVie, and Gilead Sciences.
8 reports, 1 independent
Updated Aug 1
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 8
- Developments
- 1
- Repetition
- 88%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The SPDR ETF holds major pharmaceutical companies including Johnson & Johnson, Amgen, Eli Lilly, AbbVie, and Gilead Sciences.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
SPDR
family of exchange-traded funds (ETFs) managed by State Street Global Advisors
Nothing else this week.
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
Amgen
American multinational biopharmaceutical company